(Q45413414)

English

Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations

scientific article published in September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

Peter Karayiannis

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Alexopoulou A

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Theodorou M

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Dourakis SP

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sagkana E

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Papanikolopoulos K

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Archimandritis AJ

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

591-596

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with hemato-oncological neoplasias treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Intra-familial transmission of hepatitis B virus in Italy: phylogenetic sequence analysis and amino-acid variation of the core gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Sequence variations of precore/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Detection of reactivation and genetic mutations of the hepatitis B virus in patients with chronic hepatitis B infections receiving hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan, 1987-1991.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Hepatitis B virus DNA contains a glucocorticoid-responsive element

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core promoter variants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00728.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2006.00728.X

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45413414&oldid=2076852201"